Protagonist Therapeutics Inc buy JPMorgan Chase & Co.
Start price
25.09.23
/
50%
€21.80
Target price
25.09.24
€32.11
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Protagonist Therapeutics Inc | - | - |
iShares Core DAX® | 1.056% | 1.056% |
iShares Nasdaq 100 | -1.886% | -0.160% |
iShares Nikkei 225® | 2.553% | 4.359% |
iShares S&P 500 | -0.434% | 0.224% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target lowered by analysts at JPMorgan Chase & Co. from $36.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€21.80
25.07.24
25.07.24
€44.18
25.07.25
25.07.25
-
24.02.22
24.02.22
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€21.80
28.02.24
28.02.24
€34.13
28.02.25
28.02.25
-
24.02.22
24.02.22